- Menu
- Enrollment
- Empanelment
- Administrators
- Gallery
- Highend
- NK - 48
- PMJAY
- Contact us
|
| Packages | Rate |
|---|---|
| CM0471 : ECLAMPSIA WITH COMPLICATIONS REQUIRING VENTILATORY SUPPORT | 16386 |
| CM0472 : ECLAMPSIA WITH COMPLICATIONS & HELLP SYNDROME | 13729 |
| CM0473 : ABRUPTIO-PLACENTA WITH OUT COAGULATION DEFECTS (DIC) | 11544 |
| CM0474 : ABRUPTIO-PLACENTA WITH COAGULATION DEFECTS (DIC) | 15087 |
| CM0477 : SLINGS WITH MESH REPAIR FOR PROLAPSE | 10658 |
| CM0478A : VAULT PROLAPSE ABDOMINAL REPAIR WITHOUT MESH | 9477 |
| CM0478B : VAULT PROLAPSE ABDOMINAL REPAIR WITH MESH | 10068 |
| CM0480 : LAPAROSCOPIC MYOMECTOMY | 12430 |
| CM0481 A : RECANALISATION ANY TYPE- open | 8592 |
| CM0481 B : RECANALISATION ANY TYPE- lap | 11249 |
| CM0482 : STAGING LAPROTOMY FOR OVARIAN AND UTERINE CA | 15943 |
| CM0484 : LAPAROSCOPIC SLING OPERATIONS | 13906 |
| CM0485A : PPH SURGICAL MANAGEMENT - HYSTERECTOMY | 11249 |
| CM0485B : PPH SURGICAL MANAGEMENT -LIGATION/ EMBOLIZATION | 9477 |
| CM0501 : ACUTE BRONCHITIS AND PNEUMONIA WITH RESPIRATORY FAILURE | 23620 |
| CM0502 : REQUIRING VENTILATORY SUPPORT -OP POISIONING / METABOLIC COMA/SCORPION STING/ SNAKE BITE / BITES & STINGS - MAX 7 DAYS | 15750 |
| CM0626 A : DENGUE SHOCK SYNDROME -(ADULT/PAEDIATRICS) | 12991 |
| CM0626 B : DENGUE HEMORRHAGIC FEVER -(ADULT/PAEDIATRICS) | 10629 |
| CM0630 A-II : MIXED CONNECTIVE TISSUE DISEASE-(METHOTREXATE OR AZATHIOPRINE OR HYDROXY CHLOROQUINE/ PULSE CYCLOPHOSPHAMIDE THERAPY | 9448 |
| CM0631A-II : VASCULITIS (PREDNISOLONE OR METHOTREXATE OR AZATHIOPRINE/ PULSE CYCLOPHOSPHAMIDE THERAPY ) | 7086 |
| CM0631B-II : VASCULITIS (PREDNISOLONE OR METHOTREXATE OR AZATHIOPRINE/ PULSE CYCLOPHOSPHAMIDE THERAPY / INTERNAL ORGAN INVOLVEMENT REQUIRING INTRAVENOUS IMMUNOGLOBULIN/ MYCOPHENOLATE MOFETIL INDUCTION/MYCOPHENOLATE MOFETIL MAINTENANCE/ PNEUMOCOCCAL VACCINATION) | 118098 |
| CM0634 A-I : POST-TRANSPLANT IMMUNOSUPPRESSIVE TREATMENT FROM 1ST TO 6 TH MONTH AFTER TRANSPLANTATION ( LIVER) - Covered Primary package alloted under Corpus fund | 0 |
| CM0634 B : POST-TRANSPLANT IMMUNOSUPPRESSIVE TREATMENT FROM 7 TH TO 12 TH MONTH AFTER TRANSPLANTATION ( LIVER) - Covered Primary package alloted under Corpus fund | 0 |
| CM0634 C : POST-TRANSPLANT IMMUNOSUPPRESSIVE TREATMENT FROM 1ST TO 6 TH MONTH AFTER TRANSPLANTATION ( HEART & LUNG) - Covered Primary package alloted under Corpus fund | 0 |
| CM0634 D : POST-TRANSPLANT IMMUNOSUPPRESSIVE TREATMENT FROM 7 TH TO 12 TH MONTH AFTER TRANSPLANTATION ( HEART & LUNG) Covered Primary package alloted under Corpus fund | 0 |
| CM0634 E : POST-TRANSPLANT IMMUNOSUPPRESSIVE TREATMENT FROM 1ST TO 6 TH MONTH AFTER TRANSPLANTATION ( LUNG) Covered Primary package alloted under Corpus fund | 0 |
| CM0634 F : POST-TRANSPLANT IMMUNOSUPPRESSIVE TREATMENT FROM 7 TH TO 12 TH MONTH AFTER TRANSPLANTATION ( LUNG) Covered Primary package alloted under Corpus fund | 0 |
| CM0634 G : POST-TRANSPLANT IMMUNOSUPPRESSIVE TREATMENT FROM 1ST TO 6 TH MONTH AFTER TRANSPLANTATION ( COCHLEAR) Covered Primary package alloted under Corpus fund | 0 |
| CM0634 H : POST-TRANSPLANT IMMUNOSUPPRESSIVE TREATMENT FROM 7 TH TO 12 TH MONTH AFTER TRANSPLANTATION ( COCHLEAR) Covered Primary package alloted under Corpus fund | 0 |
| CM0634 I : POST-TRANSPLANT IMMUNOSUPPRESSIVE TREATMENT FROM 1ST TO 6 TH MONTH AFTER TRANSPLANTATION ( AUDITORY BRAINSTEM IMPLANTATION) Covered Primary package alloted under Corpus fund | 0 |
| CM0634 J : POST-TRANSPLANT IMMUNOSUPPRESSIVE TREATMENT FROM 7 TH TO 12 TH MONTH AFTER TRANSPLANTATION ( AUDITORY BRAINSTEM IMPLANTATION) Covered Primary package alloted under Corpus fund | 0 |
| CM0634 M : POST-TRANSPLANT IMMUNOSUPPRESSIVE TREATMENT FROM 1ST TO 6 TH MONTH AFTER TRANSPLANTATION ( ALLOGENIC BONE MARROW / STEM CELL TRANSPLANTATION) - Covered Primary package alloted under Corpus fund | 0 |
| CM0634 N : POST-TRANSPLANT IMMUNOSUPPRESSIVE TREATMENT FROM 7 TH TO 12 TH MONTH AFTER TRANSPLANTATION ( ALLOGENIC BONE MARROW / STEM CELL TRANSPLANTATION) - Covered Primary package alloted under Corpus fund | 0 |
| CM0634 O : POST-TRANSPLANT IMMUNOSUPPRESSIVE TREATMENT FROM 1ST TO 6 TH MONTH AFTER TRANSPLANTATION ( AUTOLOGOUS BONE MARROW / STEM CELL TRANSPLANTATION) - Covered Primary package alloted under Corpus fund | 0 |
| CM0634 P : POST-TRANSPLANT IMMUNOSUPPRESSIVE TREATMENT FROM 7 TH TO 12 TH MONTH AFTER TRANSPLANTATION ( AUTOLOGOUS BONE MARROW / STEM CELL TRANSPLANTATION) - Covered Primary package alloted under Corpus fund | 0 |
| CM0707-II : ACUTE PANCREATITIS - CONSERVATIVE MANAGEMENT / MILD / MODERATE / SEVERE MEDICAL / IMAGE GUIDED DRAINAGE OF PANCREATIC COLLECTIONS | 33038 |
| CM0734-II : URETEROCELE SURGERY | 17715 |
| CM0754 : LEIOMYOMA EXCISION | 7086 |
| CM0822 A-II : SOFT TISSUE INJURY - LACERATION (SUTURING) /WOUND DEBRIDEMENT | 354 |
| CM0822 B-II : SOFT TISSUE INJURY - DEEP WOUND [NERVE/TENDON REPAIR] | 2952 |
| CM0825A : POLYTRAUMA/HEAD INJURY MINOR (only lacerations less than 10 cm) | 1476 |
| CM0825B : POLYTRAUMA/HEAD INJURY MINOR (deep / pitted wound exposing scalp/ bone requiring debridement and suturing) | 4133 |
| CM0826 : POLYTRAUMA/HEAD INJURY MAJOR (with fractures, intracranial bleeding) | 14762 |
| CM0827-I : SEVERE MYOCARDITIS/CONGENITAL HEART DISEASE PRESENTING WITH OR WITHOUT / INFECTION / FAILURE / CARDIOGENIC SHOCK / SEPTIC SHOCK / INFECTIVE ENDOCARDITIS/ CYANOTIC SPELL - NON VENTILATED | 23620 |
| CM0828-I : SEVERE MYOCARDITIS/CONGENITAL HEART DISEASE PRESENTING WITH OR WITHOUT / INFECTION / FAILURE / CARDIOGENIC SHOCK / SEPTIC SHOCK / INFECTIVE ENDOCARDITIS/ CYANOTIC SPELL - VENTILATED | 29525 |
| CM0829-I : STATUS EPILEPTICUS WITH MECHANICAL VENTILATION -(ADULT/PAEDIATRIC ) | 23620 |
| CM0830 : DIABETIC KETOACIDOSIS - TYPE I / TYPE II | 17715 |
| CM0831-I : CHRONIC RENAL FAILURE WITH HEMODIALYSIS/ERYTHROPOIETIN / IRON | 10127 |
| CM0832-I : ACUTE RENAL FAILURE WITHOUT HEMODIALYSIS/ERYTHROPOIETIN / IRON | 5728 |
| CM0833-I : ACUTE RENAL FAILURE WITH HEMODIALYSIS/ ERYTHROPOIETIN / IRON | 6673 |
| CM0834-I : ACUTE RENAL FAILURE / CRF WITH VENTILATOR CARE | 15766 |
| CM0835A-I : ACUTE RENAL FAILURE / CRF - CONTINUOUS RENAL REPLACEMENT THERAPY-SCUF & SLED | 33658 |
| CM0835B-I : ACUTE RENAL FAILURE / CRF - CONTINUOUS RENAL REPLACEMENT THERAPY - CVVH/CVVHD | 45468 |
| CM0837-I : PYOGENIC /TB /VIRAL/ FUNGAL -MENINGITIS/ MENINGOENCEPHALITIS - NON VENTILATED | 17715 |
| CM0838-I : PYOGENIC /TB /VIRAL/ FUNGAL -MENINGITIS/ MENINGOENCEPHALITIS - WITH VENTILATORY SUPPORT | 29525 |
| CM0839-I : NEURO TUBERCULOSIS/NEUROCYSTICERCOSIS/ TUBERCULOMA | 7086 |
| CM0840 A : IDIPOPATHIC THROMBOCYTOPENIC PURPURA | 23620 |
| CM0840 B : TTP | 35429 |
| CM0841 A : ANY COAGULATION DISORDERS | 29525 |
| CM0841 B : DIC | 14762 |
| CM0843A : MULTI SYSTEM ORGAN FAILURE- ARDS WITHOUT DIC(BLOOD PRODUCTS) | 66087 |
| CM0843B : MULTI SYSTEM ORGAN FAILURE- ARDS WITH DIC(BLOOD PRODUCTS) | 90387 |
| CM0844 : ENTERIC ENCEPHALOPATHY | 11940 |
| CM0845 : LEPTOSPIROSIS WITH HEPATIC INVOLVEMENT | 11751 |
| CM0846 : SUBMERSION INJURY WITH VENTILATORY SUPPORT | 15943 |
| CM0847 : ARDS WITH VENTILATORY SUPPORT | 49631 |
| CM0848-I : RESPIRATORY FAILURE OF ANY CAUSE REQUIRING HIGH FREQUENCY VENTILATION | 33186 |
| CM0878-II : PELVIC FLOOR RECONSTRUCTION WITH MESH | 18158 |
| CM0879-II : LAPAROSCOPIC / LAPROTOMY - ECTOPIC RESECTION | 12607 |
| CM0881 A-I : THALASSEMIA MAJOR /HAEMOGLOBINOPATHIES/ CHELATION THERAPY | 70859 |
| CM0881 B-I : SICKLE CELL ANAEMIA | 2952 |
| CM0882-I : INTERSTITAL LUNG DISEASE | 17301 |
| CM0883-I : OESOPHAGEAL VARICES /GASTRIC VARICES/PESUDO ANEURYSM - BANDING | 6023 |
| CM0887-I : END STAGE RENAL DISEASE | 8355 |
| CM0888-I : GULLAIN BARRE SYNDROME | 59049 |
| CM0889-I : OPTIC NEURITIS | 5905 |
| CM0891-I : MYASTHENIA GRAVIS | 8857 |
| CM0892 : MANAGEMENT OF COMA | 17762 |
| CM0895 : HYPER OSMOLAR NON-KETOTIC COMA | 17715 |
| CM0931-I : INVESTIGATION AND MANAGEMENT CHRONIC HEPATITIS B / C | 158697 |
| CM0932-I : CIRRHOSIS OF LIVER WITH COMPLICATIONS | 17762 |
| CM0935 : STAY IN GENERAL WARD - OBSERVATION FOR TRAUMA - PER DAY | 413 |
| CM0936 A : STAY IN ICU - MILD/MODERATE/SEVERE WITH OR WITHOUT VENTILATION (FOR TRAUMA/POST OP COMPLICATIONS) | 0 |
| CM0936 B : STAY IN ICU - MILD WITHOUT VENTILATION (FOR TRAUMA) | 590 |
| CM0936 C : STAY IN ICU - MODERATE WITHOUT VENTILATION (FOR TRAUMA) | 8857 |
| CM0936 D : STAY IN ICU - MODERATE WITH VENTILATION (FOR TRAUMA) | 14762 |
| CM0936 E : STAY IN ICU - SEVERE WITHOUT VENTILATION (FOR TRAUMA / POST OP COMPLICATIONS - Sepsis / coma) | 14762 |
| CM0936 F : STAY IN ICU - SEVERE WITH VENTILATION (FOR TRAUMA / POST OP COMPLICATIONS - Sepsis / Coma) | 29525 |
| CM0959 : CYSTIC FIBROSIS | 21612 |
| CM0960 : SEPTIC SHOCK (ICU MANAGEMENT) | 25421 |
| CM0962-I : NEPHROTIC SYNDROME | 9504 |
| CM0963-I : NEPHROTIC SYNDROME WITH COMPLICATIONS | 15350 |
| CM0964-I : ACUTE DISSEMINATED ENCEPHALOMYELITIS | 29525 |
| CM0967-I : TOXIC/DRUG INDUCED LIVER INJURY | 15825 |
| CM0968 : MALIGNANT ASCITES | 3336 |
| CM0982 : OP /ANY POISIONING - CONSERVATIVE MANAGEMENT OR WITHOUT VENTILATORY SUPPORT (ONLY WITH FIR ) | 10629 |
| CM0987 : ACUTE SEVERE ASTHMA WITH VENTILATION | 30233 |
| CM0988 : CRITICAL CARE ICU MANAGEMENT ( RESPIRATORY DISTRESS/ METABOLIC COMA/MULTIORGAN DYSFUNCTION/SEPTIC SHOCK/OTHERS WITH VENTILATION | 15750 |
| CM0989A : CRITICAL CARE ICU MANAGEMENT -CRITICAL LIMB ISCHEMIA (heparinisation) | 11810 |
| CM0989B : CRITICAL CARE ICU MANAGEMENT -CRITICAL LIMB ISCHEMIA (SK) | 14762 |
| CM0989C : CRITICAL CARE ICU MANAGEMENT -CRITICAL LIMB ISCHEMIA (rTPA) | 44287 |
| FUP0076A : MULTI SYSTEM ORGAN FAILURE- WITH OR WITHOUT /ARDS/DIC(BLOOD PRODUCTS) - First Qtr | 1800 |
| FUP0076B : MULTI SYSTEM ORGAN FAILURE- WITH OR WITHOUT /ARDS/DIC(BLOOD PRODUCTS) - Next 3 Qtrs | 1000 |
| FUP0077A : MULTI SYSTEM ORGAN FAILURE- WITH OR WITHOUT /ARDS/DIC(BLOOD PRODUCTS) - First Qtr | 1800 |
| FUP0077B : MULTI SYSTEM ORGAN FAILURE- WITH OR WITHOUT /ARDS/DIC(BLOOD PRODUCTS) - Next 3 Qtrs | 1000 |
| FUP0101A : PPH SURGICAL MANAGEMENT - HYSTERECTOMY/LIGATION/ EMBOLIZATION - First Qtr | 1000 |
| FUP0101B : PPH SURGICAL MANAGEMENT - HYSTERECTOMY/LIGATION/ EMBOLIZATION - Next 3 Qtrs | 500 |
| FUP0102A : PPH SURGICAL MANAGEMENT - HYSTERECTOMY/LIGATION/ EMBOLIZATION - First Qtr | 2500 |
| FUP0102B : PPH SURGICAL MANAGEMENT - HYSTERECTOMY/LIGATION/ EMBOLIZATION - Next 3 Qtrs | 1000 |
| FUP0103A : THALASSEMIA MAJOR/HAEMOGLOBINOPATHIES/ CHELATION THERAPY/SICKLE CELL ANAEMIA - First Qtr | 2500 |
| FUP0103B : THALASSEMIA MAJOR/HAEMOGLOBINOPATHIES/ CHELATION THERAPY/SICKLE CELL ANAEMIA - Next 3 Qtrs | 2500 |
| CM0630 B -II-c : MIXED CONNECTIVE TISSUE DISEASE - WITH GANGRENE ON IV PROSTACYCLIN | 4134 |
| CM0630 B -II-d : MIXED CONNECTIVE TISSUE DISEASE - PNEUMOCOCCAL VACCINATION | 2953 |
| CM0631A-II -a : VASCULITIS - PREDNISOLONE OR METHOTREXATE OR AZATHIOPRINE | 1772 |
| CM0631A-II -b : VASCULITIS - PULSE CYCLOPHOSPHAMIDE THERAPY | 1772 |
| CM0630 A-I-a-ii : MIXED CONNECTIVE TISSUE DISEASE- PULSE CYCLOPHOSPHAMIDE THERAPY | 1772 |
| CM0630 A-I-b-ii :MIXED CONNECTIVE TISSUE DISEASE-METHOTREXATE OR AZATHIOPRINE OR HYDROXY CHLOROQUINE | 1772 |
| CM0630 B -II-a : MYCOPHENOLATE MOFETIL INDUCTION | 3543 |
| CM0630 B -II-b : MYCOPHENOLATE MOFETIL MAINTENANCE | 1772 |
| CM0630 B -II-e : MIXED CONNECTIVE TISSUE DISEASE-(METHOTREXATE OR AZATHIOPRINE OR HYDROXY CHLOROQUINE/ PULSE CYCLOPHOSPHAMIDE THERAPY/ MYCOPHENOLATE MOFETIL INDUCTION/MYCOPHENOLATE MOFETIL MAINTENANCE/ WITH GANGRENE ON IV PROSTACYCLIN/ PNEUMOCOCCAL VACCIN | 17715 |
| CM0631A-II-c : VASCULITIS (PREDNISOLONE OR METHOTREXATE OR AZATHIOPRINE/ PULSE CYCLOPHOSPHAMIDE THERAPY )(including Diagnostic evaluation - 1st time) | 7086 |
| CM0707-II-A : ACUTE MILD PANCREATITIS - CONSERVATIVE MANAGEMENT | 17715 |
| CM0707-II-B : ACUTE MODERATE PANCREATITIS - CONSERVATIVE MANAGEMENT | 23620 |
| CM0707-II-C : ACUTE SEVERE PANCREATITIS - CONSERVATIVE MANAGEMENT | 33038 |
| CM0881 A-I-a : THALASSEMIA MAJOR (upto) | 4134 |
| CM0931-I-B : MANAGEMENT CHRONIC HEPATITIS B / C - ENTECAVIR 1 MG 30 TABS | 1800 |
| CM0931-I-C : MANAGEMENT CHRONIC HEPATITIS B / C - ENTECAVIR 0.5MG 30 TABS | 3500 |
| CM0931-I-F : MANAGEMENT CHRONIC HEPATITIS B / C - SOFOSBUVIR 400 MG 28 TABS | 2000 |
| CM0931-I-H : MANAGEMENT CHRONIC HEPATITIS B / C - SOFOSBUVIR 400 MG 28 TABS + VELPATASVIR 100 28 TABS | 6000 |
| CM0931-II-B : MANAGEMENT CHRONIC HEPATITIS B / C - ENTECAVIR 1 MG 30 TABS | 4500 |
| CM0931-II-D : MANAGEMENT CHRONIC HEPATITIS B / C - TELBUVUDINE 600MG 30 TABS | 16000 |
| CM0931-II-F : MANAGEMENT CHRONIC HEPATITIS B / C - SOFOSBUVIR 400 MG 28 TABS | 11000 |
| CM0931-I-ii : INVESTIGATION OF CHRONIC HEPATITIS B / C (VIRAL LOAD) | 10000 |
| CM0931-II-I : MANAGEMENT CHRONIC HEPATITIS B / C - SOFOSBUVIR 400 MG 28 TABS + LEDIPASVIR 90 28 TABS | 15000 |
| CM0931-II-i i: INVESTIGATION OF CHRONIC HEPATITIS B / C (VIRAL LOAD) | 10000 |
| CM0931-I-J : MANAGEMENT CHRONIC HEPATITIS B / C INTERFERON WILL BE APPROVED BASED ON DOSAGE) | 1000 |
| CM0774 B : LAPROSCOPIC ASSISTED VAGINAL HYSTERECTOMY | 11839 |
| CM1191 : Abdominal Perineal neo construction Cx + Uteria + Vagina | 11810 |
| CM1198 : Brust abdomen repair | 8267 |
| CM1212 : Intrauterine transfusions | 5905 |
| CM1362 : Blood and blood component transfusion (admission for a diagnostic procedure leading to treatment requiring admission, e.g. bone marrow and bone biopsy, endoscopy, liver biopsy, bronchoscopy, CT/MRI under GA, broncho-alveolar lavage, lumbar punctu | 0 |
The Project Director
Tamil Nadu Health Systems Project (TNHSP)
3rd Floor, DMS Annex New Building
259 Anna Salai, Teynampet
Chennai - 600 006, Tamil Nadu.
CMCHIS Project Office Chief Minister's Comprehensive Health Insurance Scheme
No.226,Om Sakthi Towers, Kilpauk Garden Road, Kilpauk, Chennai-600010, Tamil Nadu
Scan QR Code or
Click Here
to Download the Mobile app for Beneficiary